The identification of essential effector genes in lupus has provided important information both in terms of the molecules, mechanisms and pathways involved in the disease process and in identifying possible therapeutic targets. Currently, however, identification of such genes requires substantial breeding, is relatively inefficient, and is limited by both the availability of knockout genes and the requirement that the function of the gene be known. Recently, the forward genetics approach using ENU mutagenesis has been applied successfully in both large and small projects to dissect specific molecular pathways involved in normal and disease states. Although application of this strategy to spontaneous models of SLE is precluded by a number of factors (including the requirement that crosses, to map ENU mutations, must have homogeneous disease severity), published and preliminary data provide strong support for using the mercury-induced autoimmunity model (HgIA) to identify essential effector genes relevant to spontaneous SLE. This approach has the potential for identifying most of the major genes required for the development of HgIA, of which many will be applicable to SLE, and furthermore, in contrast to the current methods, it does not require prior knowledge about the function of the mutated genes in autoimmunity. By potentially opening up the entire genomic repertoire for screening, this proposed project is likely to identify new classes of genes and novel mechanisms. To apply the ENU approach to define essential effector genes in HgIA and SLE, two specific aims are proposed.
Aim 1 will generate ENU mutants that are resistant to the systemic autoimmunity induced by mercuric chloride. We propose to screen a total of 800 ENU-mutated gametes, which would cover ~12,700 recessive loss-of-function mutations equivalent to about half the genome.
Aim 2 will map and identify the specific ENU-induced genetic alteration in selected mutants. The results of the proposed studies should define many of the early components and mechanisms required for the production of autoantibodies in SLE and will likely identify novel genes and pathways that could be targeted for therapeutic intervention. ? ? ?
| Koh, Yi Ting; Scatizzi, John C; Gahan, Jennifer D et al. (2013) Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells. J Immunol 190:4982-90 |
| Kono, Dwight H; Baccala, Roberto; Theofilopoulos, Argyrios N (2013) TLRs and interferons: a central paradigm in autoimmunity. Curr Opin Immunol 25:720-7 |
| Pollard, Kenneth Michael; Kono, Dwight H (2013) Requirements for innate immune pathways in environmentally induced autoimmunity. BMC Med 11:100 |
| Pollard, Kenneth M; Cauvi, David M; Toomey, Christopher B et al. (2013) Interferon-? and systemic autoimmunity. Discov Med 16:123-31 |
| Germolec, Dori; Kono, Dwight H; Pfau, Jean C et al. (2012) Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. J Autoimmun 39:285-93 |
| Pollard, K Michael; Hultman, Per; Toomey, Christopher B et al. (2012) Definition of IFN-?-related pathways critical for chemically-induced systemic autoimmunity. J Autoimmun 39:323-31 |
| Pollard, Kenneth M; Hultman, Per; Toomey, Christopher B et al. (2011) ?2-microglobulin is required for the full expression of xenobiotic-induced systemic autoimmunity. J Immunotoxicol 8:228-37 |
| Theofilopoulos, Argyrios N; Kono, Dwight H; Beutler, Bruce et al. (2011) Intracellular nucleic acid sensors and autoimmunity. J Interferon Cytokine Res 31:867-86 |
| Arandjelovic, Sanja; Wickramarachchi, Dilki; Hemmers, Saskia et al. (2010) Mast cell function is not altered by Coronin-1A deficiency. J Leukoc Biol 88:737-45 |
| Pollard, K Michael; Hultman, Per; Kono, Dwight H (2010) Toxicology of autoimmune diseases. Chem Res Toxicol 23:455-66 |
Showing the most recent 10 out of 13 publications
